We found that WZ35 combined with cisplatin exhibited potent synergistic effect to inhibit the proliferation of human gastric cancer cells, and further demonstrated that TrxR1 activity was involved in the synergistic effect in vitro and in vivo. Here, TXNRD1 is linked to gastric cancer.